[HTML][HTML] … and safety of rivaroxaban plus clopidogrel versus aspirin plus clopidogrel in patients with coronary atherosclerotic heart disease and gastrointestinal disease …

T Zhou, Y Gong, J Li, Y Wang, X Wang - Trials, 2023 - Springer
… as clopidogrel, also have an increased risk of GIB, but by a different mechanism from aspirin,
increasing the risk … a new strategy for the secondary prevention of CHD combined with GID …

Effect of ticagrelor monotherapy vs ticagrelor with aspirin on major bleeding and cardiovascular events in patients with acute coronary syndrome: the TICO …

BK Kim, SJ Hong, YH Cho, KH Yun, YH Kim, Y Suh… - Jama, 2020 - jamanetwork.com
prevention of cardiovascular disease, discontinuing aspirin while … Key exclusion criteria
included increased risk of bleeding … clopidogrel or prasugrel was used in the 8.2% of the patients

P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events

F Gragnano, D Cao, L Pirondini, A Franzone… - … College of Cardiology, 2023 - jacc.org
… compared with aspirin alone, albeit with a higher risk of major bleeding … of cardiovascular
events with clopidogrel monotherapy compared with aspirin in a heterogeneous patient cohort …

[HTML][HTML] … with or without PPIs for the secondary prevention of cardiovascular diseases in patients at high risk of upper gastrointestinal bleeding: A systematic review and …

W Wu, J Liu, H Yu, Z Jiang - Experimental and …, 2020 - spandidos-publications.com
… The funnel plot for overall meta-analysis reports on recurrent CV events between the aspirin
plus PPIs and clopidogrel groups. Visual assessment of the funnel plot shows no asymmetry …

[HTML][HTML] Aspirin for primary and secondary prevention of cardiovascular disease: time to stop?

JGF Cleland - Thrombosis and Haemostasis, 2022 - thieme-connect.com
… at higher risk of both cardiovascular disease and cancer, the balance of risk and benefit of
primary prevention for aspirin … function but clopidogrel has only marginally greater effects on …

An aspirin-free versus dual antiplatelet strategy for coronary stenting: STOPDAPT-3 randomized trial

M Natsuaki, H Watanabe, T Morimoto, K Yamamoto… - Circulation, 2024 - Am Heart Assoc
… after PCI without increasing cardiovascular events, but its efficacy … clopidogrel was associated
with no signal of harm in terms of … patients at high risk for bleeding within 1 month after PCI. …

Network meta-analysis of ticagrelor for stroke prevention in patients at high risk for cardiovascular or cerebrovascular events

A Bálint, D Tornyos, O El Alaoui El Abdallaoui, P Kupó… - Stroke, 2021 - Am Heart Assoc
patients with high risk for cardiovascular or cerebrovascular disease, defined as coronary
artery disease… % lower with aspirin plus clopidogrel and 20% lower with aspirin plus ticagrelor (…

Antithrombotic therapy for atherosclerotic cardiovascular disease risk mitigation in patients with coronary artery disease and diabetes mellitus

D Capodanno, DJ Angiolillo - Circulation, 2020 - Am Heart Assoc
… The higher risk of atherosclerotic cardiovascular disease (… by aspirin because of the presence
of vascular disease impairing … patients with DM treated with clopidogrel, 21 vascular events

P2Y12 inhibitors versus aspirin monotherapy for long-term secondary prevention of atherosclerotic cardiovascular disease events: a systematic review and meta …

A Al-Abdouh, W Abusnina, M Mhanna… - … problems in cardiology, 2022 - Elsevier
… The HOST-EXAM 6 (Aspirin vs clopidogrel for chronic … the risk of myocardial infarction
and stroke among patients using … for patients with acute myocardial infarction and high risk

… of clopidogrel monotherapy after 1 to 2 months of dual antiplatelet therapy with 12 months of dual antiplatelet therapy in patients with acute coronary syndrome: the …

H Watanabe, T Morimoto, M Natsuaki… - … cardiology, 2022 - jamanetwork.com
… PCI, patients in the 1- to 2-month DAPT group were to stop … DAPT with aspirin and clopidogrel.
Others might argue that … for the numerically higher rate of cardiovascular events in the 1- …